27–28 April 2026 | Brussels and online (hybrid)
The European Alliance for Cardiovascular Health (EACH) highlights the upcoming PERFECTO Closing Event, titled “Advancing Screening for Inherited Lipid Disorders – Untapped Potential for the Safe Hearts Plan in Europe.”
The event is organised by the FH Europe Foundation, coordinator of the EU4Health-funded PERFECTO project and a member of EACH, and is held under the auspices of the Cyprus Presidency of the Council of the European Union. It will take place in a hybrid format in Brussels, at the Representation of the State of North Rhine-Westphalia to the European Union, and online.
Why this event matters
Cardiovascular disease remains the leading cause of mortality in Europe. Inherited lipid disorders, including familial hypercholesterolaemia (FH) and elevated lipoprotein(a) [Lp(a)], are significant but underdiagnosed risk factors.
This high-level EU Presidency event will bring together policymakers, clinicians, researchers, patient organisations and representatives from EU institutions to advance the transition from evidence to implementation. Discussions will focus on scaling up early detection and screening strategies across Member States.
The event contributes directly to EU priorities on health system resilience, prevention and citizen wellbeing, in line with the Strategic Agenda 2024–2029 and the Trio Programme.
Endorsement
The event is endorsed by leading international cardiovascular and patient organisations, including the European Alliance for Cardiovascular Health (EACH).
Registration
More information and registration are available at:
https://perfecto-fh.eu/perfecto-closing-event/
